Rectal suppositories are used to administer a predetermined drug dosage to treat a variety of diseases and symptoms. Rectal suppositories are designed to melt inside the body allowing the active pharmaceutical ingredient (API) contained within the rectal suppository to be absorbed by the mucosa lining of the rectum in order to treat a patient locally or systemically. Suppositories are typically used to administer drugs to patients who cannot take the drug orally for a variety of reasons, such as uncontrollable vomiting or nausea, chronic illnesses, and gastrointestinal diseases. In addition, children, the elderly, and patients unable to care for themselves may also use rectal suppositories to treat a variety of symptoms and conditions. In other cases, specific drugs can cause extreme stomach upset or are inactivated in the stomach or liver and are, therefore, better tolerated by rectal administration.
It is common practice to administer rectal suppositories manually using a finger while the patient is, for example, lying on their left side in the fetal position, and after having emptied their bowel. After insertion of the suppository, the patient is instructed to remain on their side in the fetal position for an extended period of time (e.g., at least 30 minutes) while the suppository has time to melt within the rectum and the body begins the absorption process.
Applicators for administering rectal suppositories have been proposed.
Devices and associated methods for single-use insertion of a suppository are provided.
A method for providing a single-use suppository insertion device according to an example embodiment includes activating a disabling feature of a barrel or a plunger during operational motion of the plunger relative to the barrel, such as during insertion of or withdrawal away from a suppository.
Activating the disabling feature can include engaging, e.g., irreversibly engaging, the disabling feature of the plunger or the barrel with a structural element of the barrel or the plunger. Activating the disabling feature can include activating the disabling feature during insertion of or withdrawal away from a suppository, such as withdrawal of the plunger through the barrel and away from the suppository.
The structural element can include a feature complementary to the disabling feature and can engage the disabling feature with the complementary feature. For example, the complementary feature of the structural element can include a concave surface, and the disabling feature can include a convex surface. The structural element can extend from an inner surface of the barrel, and can be a spacing element, to space the plunger from the barrel.
The disabling feature can be a protrusion extending outward from an outer surface of the plunger. For example, the disabling feature and the structural element can form a ratchet, to allow motion in one direction but prevent motion in another (e.g., opposite) direction.
The structural element can be coupled to or defined by the barrel, and the disabling feature can be coupled to or defined by the plunger. Engaging the disabling feature with the structural element causes the structural element to uncouple from the barrel. For example, a flange can be provided that couples the structural element to the barrel. The flange can be configured to break at a perforation of the flange to cause the structural element to uncouple, which may be a full or partial uncoupling, from the barrel.
The method for providing a single-use suppository insertion device can further include coupling the plunger to an insert receivable in the barrel, the insert including the disabling feature. The plunger can include a fitting to couple to the insert.
A single-use suppository device according to an example embodiment includes a barrel, a plunger configured to be movably coupled to the barrel, and a disabling feature of the barrel or the plunger configured to be activated during operational motion of the plunger relative to the barrel, such as during insertion of or withdrawal away from a suppository.
The single-use suppository insertion device can further include a structural element of the barrel or the plunger configured to engage with the disabling feature of the barrel or the plunger during insertion of or withdrawal away from the suppository to activate the disabling feature.
The structural element, such as a spacing element, fin, protrusion etc., can be configured to maintain a gas flow path associated with the device. The structural element can be configured to engage irreversibly with the disabling feature and can include a feature complementary to the disabling feature. For example, the complementary feature of the structural element can include a concave surface, and the disabling feature can include a convex surface. The structural element can be configured to engage with the disabling feature during withdrawal of the plunger through the barrel.
The device can further include an insert receivable in the barrel and configured to couple to the plunger. The insert can include, or form, the disabling feature. The plunger can include a fitting to couple to the insert, whereby the insert moves with plunger during operational motion of the plunger relative to the barrel. The plunger can further cooperate with the insert to activate the disabling feature.
Another example embodiment of the single-use suppository insertion device may include a barrel, a plunger configured to be movably coupled to the barrel, and means for activating a disabling feature of the plunger or the barrel during operational motion of the plunger relative to the barrel, such as during insertion of or withdrawal away from a suppository.
The means for activating the disabling feature can include a structural element, or equivalents thereof, of the barrel or the plunger configured to engage with the disabling feature of the barrel or the plunger during insertion of or withdrawal away from the suppository.
Embodiments of the present invention can provide several advantages. A disabling feature, which may be provided at the barrel, the plunger, or both, can render the suppository insertion device inoperable after one time use. For example, the disabling feature, once engaged, can prevent retraction of plunger through the barrel, so that the barrel cannot be re-loaded with another suppository. The disabling feature can include a destructive component, such as one or more break-away elements, that renders the insertion device inoperable after one-time use. For example, when the break-away element(s) breaks, the plunger may no longer be engaged with the barrel, leaving the plunger to rattle around in the barrel. In other examples, the disabling feature is irreversibly engaged during operational motion of the plunger relative to barrel. Embodiments can include one or more flow paths that allow gas to flow into or out of the body during insertion of or withdrawal from the suppository, to ensure proper placement of the suppository in the desired anatomical location.
The foregoing will be apparent from the following more particular description of example embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments of the present invention.
A description of example embodiments of the invention follows.
Examples of devices and methods for inserting a suppository are described in U.S. Pat. No. 8,192,393, entitled, “Method and Apparatus For Inserting a Rectal Suppository,” issued on Jun. 5, 2012, and U.S. Pat. No. 8,419,712, entitled “Method and Apparatus For Inserting a Rectal Suppository,” issued on Apr. 16, 2013, the entire teachings of both are incorporated herein by reference.
Further examples of devices for inserting a suppository are described in U.S. patent application Ser. No. 13/840,096, entitled “Method and Apparatus For Inserting a Rectal Suppository,” published on Aug. 8, 2013 as U.S. Patent Publication No. 2013/0204182, the entire teachings of which are incorporated herein by reference.
Examples of devices and methods for manufacturing a suppository are described in International Patent Application No. PCT/US2013/065795, entitled “Suppository Insertion Device, Suppository, and Method of Manufacturing a Suppository,” published on Apr. 24, 2014 as WO 2014/063122, the entire teachings of which are incorporated herein by reference.
A ratchet is commonly understood to be a locking device or mechanism that permits movement of a part of an apparatus in one direction only, e.g., a lever or spring-loaded catch. A ratchet can include a pawl or detent for preventing backward motion while allowing forward motion of an element of the ratchet.
As shown in
As illustrated in
The device 100 can further include an insert 130 receivable in the barrel 110 and configured to couple to the plunger 115. The insert 130 can include, or provide, the disabling feature configured to be activated during operational motion of the plunger 115 relative to the barrel 110, for example, during insertion of or withdrawal away from a suppository. The plunger 115 can include a fitting 135 to couple to the insert 130. In the example shown, the insert 130 includes one or more protrusions 134 that extend inward from an inside wall of the insert. The fitting 135 of the plunger 115 includes one or more complementary features 136 to engage the one or more protrusions 134 of the insert. The fitting 135 is configured to couple to the insert 130 and apply a force to the insert to cause a portion of the insert to expand. The barrel 110 can be configured to restrain expansion of the insert 130, such as while the insert 130 is at least partially within the barrel. Other ways of coupling the plunger 115 to the insert 130 and allowing the insert to expand may be used.
As illustrated in
The plunger 115 can engage with the insert 130 before or after loading of the suppository 105. As shown, the fitting 135 is positioned at the insertion end 114 of the plunger 115, but may be positioned anywhere along the length of the plunger.
In an alternative embodiment of an insertion device 200 illustrated in
As with plunger 115 of device 100, the plunger 315 has a gripping end (e.g., a finger interface end) 316 and an insertion end 314. The plunger 315 is appropriately sized and shaped to extend through the barrel 310. A stepped portion 318 is provided at the gripping end 316 of the plunger 315. The stepped portion 318 can be configured to ensure that a gas flow path associated with the device 300, e.g., gas flow path 320, is not obstructed during use of the device. The plunger 315 can be configured to be substantially longer than the barrel 310, thereby allowing the plunger 315 to extend beyond the insertion end 308 of the barrel 310.
As illustrated in
As illustrated in
As with plunger 115, the plunger 315 may be further configured to maintain a second gas flow path 325 (
With any of the single-use insertion devices described herein, a mechanism can be provided to prevent premature advancement of the plunger into the barrel, thus preventing premature activation of the disabling feature. The mechanism can be an insert or a component of the barrel, the plunger, or both. The insert or component can prevent the device from locking prematurely, such as while a user is handling the device, loading the suppository, or at any other time before the suppository has been delivered. The mechanism can include a break-away locking mechanism or a removable clip or cuff, as will be described next with respect to
The break-away member 350 and cuff 355 can be made of the same material as the plunger and the barrel, such as plastic, elastomer, paper, or other suitable material. The break-away member 350 and cuff 355 can each be separate component or can be co-manufactured (e.g., co-molded) with the plunger, the barrel, or both. Each mechanism 350, 355 can be configured to be removed by the user, e.g., broken off, torn off, released, etc., when the user is ready to administer the suppository.
Described herein are example embodiments of a single-use suppository insertion device 100, 200, 300, 300′, 400, 500 that include a barrel, a plunger and a disabling feature. Embodiments of the single-use suppository insertion device can further include a structural element of the barrel or the plunger configured to engage with the disabling feature of the barrel or the plunger during insertion of or withdrawal away from the suppository to activate the disabling feature. The structural element can be configured to engage irreversibly with the disabling feature and can include a feature complementary to the disabling feature. For example, the complementary feature of the structural element can include a concave surface, and the disabling feature can include a convex surface. The structural element can extend from an inner surface of the barrel and can be a spacing element. The disabling feature can be a protrusion extending outward from an outer surface of the plunger. For example, the disabling feature and the structural element can form a ratchet. The structural element can be coupled to or defined by the barrel, and the disabling feature can be coupled to or defined by the plunger. Engagement of the disabling feature with the structural element can cause the structural element to uncouple from the barrel. The structural element can be configured to engage with the disabling feature during withdrawal of the plunger through the barrel.
The teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety.
While this invention has been particularly shown and described with references to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
This application is a divisional of U.S. application Ser. No. 16/098,623, which is the U.S. National Stage of International Application No. PCT/US2017/032142, filed on May 11, 2017, which designates the U.S., published in English, which claims the benefit of U.S. Provisional Application No. 62/335,179, filed on May 12, 2016. The entire teachings of the above applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
330764 | Worley | Nov 1884 | A |
504512 | Bailey | Sep 1893 | A |
2281600 | Ross | May 1942 | A |
2290571 | Peyton | Jul 1942 | A |
2443207 | Tedford | Jun 1948 | A |
2503445 | Lermer | Apr 1950 | A |
2532598 | Boeger | Dec 1950 | A |
2680442 | Linzmayer | Jun 1954 | A |
2709436 | Lynn | May 1955 | A |
2754823 | Miller | Jul 1956 | A |
3015332 | Brecht | Jan 1962 | A |
3139886 | Tallman et al. | Jul 1964 | A |
3220413 | Sunnen | Nov 1965 | A |
3667465 | Voss | Jun 1972 | A |
3780735 | Crouter et al. | Dec 1973 | A |
3835856 | Warncke | Sep 1974 | A |
3840010 | Giglio | Oct 1974 | A |
4248229 | Miller | Feb 1981 | A |
4341211 | Kline | Jul 1982 | A |
4341221 | Testerman | Jul 1982 | A |
4361150 | Voss | Nov 1982 | A |
4406655 | Clayton | Sep 1983 | A |
4421504 | Kline | Dec 1983 | A |
4752288 | Hussey | Jun 1988 | A |
4990136 | Geria | Feb 1991 | A |
5152068 | Meister et al. | Oct 1992 | A |
D330764 | Lorentzon | Nov 1992 | S |
5160689 | Kamen | Nov 1992 | A |
5213566 | Weissenburger | May 1993 | A |
5330427 | Weissenburger | Jul 1994 | A |
5352681 | Wittebrood et al. | Oct 1994 | A |
5354325 | Chive et al. | Oct 1994 | A |
5460617 | Minkus et al. | Oct 1995 | A |
5656283 | Brummer et al. | Aug 1997 | A |
5662601 | Snead | Sep 1997 | A |
5788664 | Scalise | Aug 1998 | A |
5860946 | Hofstätter | Jan 1999 | A |
6056714 | McNelis et al. | May 2000 | A |
D436661 | Berry | Jan 2001 | S |
6190348 | Tiemann et al. | Feb 2001 | B1 |
6245776 | Skwierczynski et al. | Jun 2001 | B1 |
6380455 | Moder et al. | Apr 2002 | B1 |
6486168 | Skwierczynski et al. | Nov 2002 | B1 |
6500460 | Bergeron et al. | Dec 2002 | B1 |
D471980 | Caizza | Mar 2003 | S |
6706728 | Hedenstrom et al. | Mar 2004 | B2 |
6740333 | Beckett et al. | May 2004 | B2 |
6786883 | Shippert | Sep 2004 | B2 |
6916308 | Dixon et al. | Jul 2005 | B2 |
7070581 | Manera et al. | Jul 2006 | B2 |
7081110 | Karapasha | Jul 2006 | B2 |
7104968 | Swick | Sep 2006 | B2 |
D529603 | Knickerbocker et al. | Oct 2006 | S |
7122025 | Nestenborg | Oct 2006 | B1 |
7149574 | Yun et al. | Dec 2006 | B2 |
7192607 | Bergeron et al. | Mar 2007 | B2 |
7198612 | Swick | Apr 2007 | B2 |
7217252 | Swick | May 2007 | B2 |
7361168 | Makower et al. | Apr 2008 | B2 |
D572362 | Edgett et al. | Jul 2008 | S |
D579786 | Py et al. | Nov 2008 | S |
7465295 | Bergeron et al. | Dec 2008 | B2 |
D585988 | Kinnard | Feb 2009 | S |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7591808 | DiPiano et al. | Sep 2009 | B2 |
D608659 | Py et al. | Jan 2010 | S |
7666160 | Rajala et al. | Feb 2010 | B2 |
8192393 | Ensign | Jun 2012 | B2 |
8419712 | Ensign | Apr 2013 | B2 |
9662481 | Davagian | May 2017 | B2 |
10149967 | Davagian et al. | Dec 2018 | B2 |
10525242 | Davagian | Jan 2020 | B2 |
11224727 | Davagian | Jan 2022 | B2 |
11298515 | Davagian | Apr 2022 | B2 |
20020048601 | Beckett et al. | Apr 2002 | A1 |
20020058674 | Hedenstrom et al. | May 2002 | A1 |
20030045543 | Hedenstrom et al. | Mar 2003 | A1 |
20030088217 | Bergeron et al. | May 2003 | A1 |
20030233077 | Swick | Dec 2003 | A1 |
20030233078 | Swick | Dec 2003 | A1 |
20040047910 | Beckett et al. | Mar 2004 | A1 |
20040249352 | Swick | Dec 2004 | A1 |
20040249416 | Yun et al. | Dec 2004 | A1 |
20040260252 | DiPiano et al. | Dec 2004 | A1 |
20050004533 | Smith | Jan 2005 | A1 |
20050021092 | Yun et al. | Jan 2005 | A1 |
20050143378 | Yun et al. | Jun 2005 | A1 |
20050143788 | Yun et al. | Jun 2005 | A1 |
20050153885 | Yun et al. | Jul 2005 | A1 |
20050240241 | Yun et al. | Oct 2005 | A1 |
20050256028 | Yun et al. | Nov 2005 | A1 |
20050273038 | Osborn, III et al. | Dec 2005 | A1 |
20060034847 | Yun et al. | Feb 2006 | A1 |
20060035974 | Yun et al. | Feb 2006 | A1 |
20060069012 | Yun et al. | Mar 2006 | A1 |
20060161105 | Mori et al. | Jul 2006 | A1 |
20060184100 | Studin | Aug 2006 | A1 |
20060206149 | Yun | Sep 2006 | A1 |
20070073267 | Muller | Mar 2007 | A1 |
20070112327 | Yun et al. | May 2007 | A1 |
20070129668 | Swick | Jun 2007 | A1 |
20070185436 | Swick | Aug 2007 | A1 |
20080038377 | Citow | Feb 2008 | A1 |
20080097286 | Cleator et al. | Apr 2008 | A1 |
20080161752 | Rajala et al. | Jul 2008 | A1 |
20080167598 | Gann et al. | Jul 2008 | A1 |
20080167599 | Osborn et al. | Jul 2008 | A1 |
20080300575 | Cleator et al. | Dec 2008 | A1 |
20080319269 | Longo et al. | Dec 2008 | A1 |
20100010471 | Ladd et al. | Jan 2010 | A1 |
20100087797 | Ensign | Apr 2010 | A1 |
20100145379 | Isham | Jun 2010 | A1 |
20110002966 | Lovett | Jan 2011 | A1 |
20130123712 | Ivosevic | May 2013 | A1 |
20130204182 | Ensign | Aug 2013 | A1 |
20150265820 | Ensign et al. | Sep 2015 | A1 |
20170224971 | Davagian | Aug 2017 | A1 |
20190143088 | Davagian | May 2019 | A1 |
20190151636 | Davagian et al. | May 2019 | A1 |
20220088358 | Davagian et al. | Mar 2022 | A1 |
Number | Date | Country |
---|---|---|
2416896 | Jan 2001 | CN |
201586319 | Sep 2010 | CN |
3031408 | Mar 1982 | DE |
1 040 808 | Oct 2000 | EP |
1 319 420 | Jun 2003 | EP |
1 530 978 | May 2005 | EP |
2554211 | Feb 2013 | EP |
1190750 | Oct 1959 | FR |
2923999 | May 2009 | FR |
S59-181834 | Oct 1984 | JP |
H02302266 | Dec 1990 | JP |
H05-070545 | Sep 1993 | JP |
H05-279243 | Oct 1993 | JP |
H09-103467 | Apr 1997 | JP |
2001-070456 | Mar 2001 | JP |
2004526520 | Sep 2004 | JP |
2007-215732 | Aug 2007 | JP |
2012-005719 | Jan 2012 | JP |
WO 0191605 | Dec 2001 | WO |
WO 2004112755 | Dec 2004 | WO |
WO 03101525 | Dec 2005 | WO |
WO 2006063377 | Jun 2006 | WO |
WO 2006077617 | Jul 2006 | WO |
WO 2008081353 | Jul 2008 | WO |
WO 2008084453 | Jul 2008 | WO |
WO 2008102341 | Aug 2008 | WO |
WO 2010042468 | Apr 2010 | WO |
WO 2014063122 | Apr 2014 | WO |
WO 2017197100 | Nov 2017 | WO |
Entry |
---|
Banerjee, S. et al., “Inflammatory Bowel Disease Medical Therapy of Specific Clinical Presentations,” Gastroenterol Clin N Am, 31: 185-202 (2002). |
Bradshaw, A., “Rectal Suppository Insertion: The Reliability of the Evidence as a Basis for Nursing Practice,” Journal of Clinical Nursing, 16: 98-103 (2006). |
Fernandez-Becker, N.Q. et al., “Improving Delivery of Aminosalicylates in Ulcerative Colitis,” Drugs, 68(8): 1089-1103 (2008). |
Hidaka, N. et al., “Changes in the Plasma Diazepam Concentration and Its Anticonvulsant Effect After the Discharge of a Diazepam Suppository from the Rectum in Rats,” Methods Find Exp Clin Pharmacol, 29(6): 401-404 (2007). |
Howell, H.R., “Ulcerative Colitis: Achieving and Maintaining Remission,” US Pharm, 33(12): 30-37 (2008). |
Regueiro, M. et al., “Medical Management of Left-Sided Ulcerative Colitis and Ulcerative Proctitis: Critical Evaluation of Therapeutic Trials,” Inflamm Bowel Dis, 12(10): 979-994 (Oct. 2006). |
Tindall, W.N. et al., “Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs,” Supplement to Journal of Managed Care Pharmacy, 13(7, S-a): S2-S15 (with attached 2 page Evaluation) (Sep. 2007). |
Expedited Review Request, Letter and Attachments A-C from Jennifer Davagian Ensign regarding Expedited Review of 510(k) Premarket Notification, Dated: Sep. 4, 2009. |
International Search Report and Written Opinion for Int'l Application No. PCT/US2017/032142, titled: Single-Use Suppository Insertion Device And Method, date mailed: Aug. 29, 2017. |
International Preliminary Report on Patentability for Int'l Application No. PCT/US2017/032142, titled: Single-Use Suppository Insertion Device And Method, date of completion: Nov. 13, 2018. |
Non-final Office Action for U.S. Appl. No. 16/098,623, Date Mailed: Apr. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 16/098,623, Date Mailed: Dec. 8, 2021. |
Number | Date | Country | |
---|---|---|---|
20220288367 A1 | Sep 2022 | US |
Number | Date | Country | |
---|---|---|---|
62335179 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16098623 | US | |
Child | 17709125 | US |